NPDI-9t7UTw
|
Goldenseal (Hydrastis canadensis)
|
Goldenseal Characterization of Material
|
Goldenseal Characterization of Material Experiment
|
Characterization of Material
|
|
|
|
|
|
|
NPDI-0eAs4g
|
Goldenseal (Hydrastis canadensis)
|
Influence of Goldenseal Root on the Pharmacokinetics of Indinavir
|
Indinavir/ Goldenseal Root Experiment
|
In Vivo Interaction
|
negative
— No Effect (based on bioequivalence limits)
|
|
|
indinavir
|
|
goldenseal root extract
|
NPDI-j7Vnlw
|
Goldenseal (Hydrastis canadensis)
|
Repeated administration of berberine inhibits cytochromes P450 in humans
|
CYP3A4 Experiment
|
In Vivo Interaction
|
positive
— PK Interaction - Increased systemic exposure
|
|
|
midazolam
|
|
berberine
|
NPDI-3VbSWA
|
Goldenseal (Hydrastis canadensis)
|
Repeated administration of berberine inhibits cytochromes P450 in humans
|
CYP1A2 Experiment
|
In Vivo Interaction
|
negative
— No Effect (based on bioequivalence limits)
|
|
|
caffeine
|
|
berberine
|
NPDI-roGv8w
|
Goldenseal (Hydrastis canadensis)
|
Time-Dependent Inhibition of CYP2C19 by Isoquinoline Alkaloids: In Vitro and In Silico Analysis
|
CYP2C19 Inhibition by Berberine
|
In Vitro Enzyme Inhibition
|
negative
— In Vitro Enzyme Negligible Inhibition
|
|
|
dibenzylfluorescein
|
fluorescein
|
berberine
|
NPDI-nzhlHQ
|
Goldenseal (Hydrastis canadensis)
|
Repeated administration of berberine inhibits cytochromes P450 in humans
|
CYP2C19 Experiment
|
In Vivo Interaction
|
negative
— No Effect (based on bioequivalence limits)
|
|
|
omeprazole
|
|
berberine
|
NPDI-8px6rQ
|
Goldenseal (Hydrastis canadensis)
|
Repeated administration of berberine inhibits cytochromes P450 in humans
|
CYP2D6 Experiment
|
In Vivo Interaction
|
positive
— PK Interaction - Increased systemic exposure
|
|
|
dextromethorphan
|
|
berberine
|
NPDI-M8kbsQ
|
Goldenseal (Hydrastis canadensis)
|
Repeated administration of berberine inhibits cytochromes P450 in humans
|
CYP2C9 Experiment
|
In Vivo Interaction
|
positive
— PK Interaction - Increased systemic exposure
|
|
|
losartan
|
|
berberine
|
NPDI-Aw3yIw
|
Goldenseal (Hydrastis canadensis)
|
Supplementation With Goldenseal (Hydrastis canadensis), but not Kava Kava (Piper methysticum), Inhibits Human CYP3A Activity In Vivo
|
CYP3A4 Experiment - MDZ probe
|
In Vivo Interaction
|
positive
— PK Interaction - Increased systemic exposure
|
|
|
midazolam
|
|
goldenseal root extract
|
NPDI-K4rJHw
|
Goldenseal (Hydrastis canadensis)
|
In Vivo and in Vitro Study on Drug-Drug Interaction of Lovastatin and Berberine from Pharmacokinetic and HepG2 Cell Metabolism Studies
|
Induction of CYP3A4 by Berberine
|
In Vitro Enzyme Induction
|
positive
— In Vitro Enzyme Induction
|
|
|
|
|
lovastatin
|
NPDI-FANNaQ
|
Goldenseal (Hydrastis canadensis)
|
Differential inhibition of CYP1-catalyzed regioselective hydroxylation of estradiol by berberine and its oxidative metabolites
|
CYP1A1 Inhibition by Berberine
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
17-beta-estradiol
|
2-hydroxyestradiol
|
berberine
|
NPDI-FJjrAg
|
Goldenseal (Hydrastis canadensis)
|
The Effects of Berberine on the Pharmacokinetics of Ciclosporin A in Healthy Volunteers
|
CsA 6 mg/kg Experiment
|
In Vivo Interaction
|
negative
— No Effect (based on bioequivalence limits)
|
|
|
cyclosporin a
|
|
berberine
|
NPDI-6IV4Kg
|
Goldenseal (Hydrastis canadensis)
|
The Effects of Berberine on the Pharmacokinetics of Ciclosporin A in Healthy Volunteers
|
CsA 3 mg/kg Experiement
|
In Vivo Interaction
|
positive
— PK Interaction - Increased systemic exposure
|
|
|
cyclosporin a
|
|
berberine
|
NPDI-uJn2xw
|
Goldenseal (Hydrastis canadensis)
|
Effects of berberine on the blood concentration of cyclosporin A in renal transplanted recipients: clinical and pharmacokinetic study
|
CsA in Renal Transplant patients
|
In Vivo Interaction
|
positive
— PK Interaction - Increased systemic exposure
|
|
|
cyclosporin a
|
|
berberine
|
NPDI-C2C-Nw
|
Goldenseal (Hydrastis canadensis)
|
Effects of berberine on the blood concentration of cyclosporin A in renal transplanted recipients: clinical and pharmacokinetic study
|
CsA Trough measurements in 52 patients
|
In Vivo Interaction
|
positive
— PK Interaction - Increased systemic exposure
|
|
|
cyclosporin a
|
|
berberine
|
NPDI-Bi2fGw
|
Goldenseal (Hydrastis canadensis)
|
In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4 phenotypes
|
CYP3A4 Experiment
|
In Vivo Interaction
|
positive
— PK Interaction - Increased systemic exposure
|
|
|
midazolam
|
|
goldenseal root extract
|
NPDI-T6Zq4Q
|
Goldenseal (Hydrastis canadensis)
|
In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4 phenotypes
|
CYP1A2 Experiment
|
In Vivo Interaction
|
negative
— No Effect (based on bioequivalence limits)
|
|
|
caffeine
|
|
goldenseal root extract
|
NPDI-Vt7rHw
|
Goldenseal (Hydrastis canadensis)
|
In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4 phenotypes
|
CYP2E1 Experiment
|
In Vivo Interaction
|
negative
— No Effect (based on bioequivalence limits)
|
|
|
chloroxazone
|
|
goldenseal root extract
|
NPDI-fDeLbA
|
Goldenseal (Hydrastis canadensis)
|
In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4 phenotypes
|
CYP2D6 Experiment
|
In Vivo Interaction
|
positive
— PK Interaction - Increased systemic exposure
|
|
|
debrisoquine
|
|
goldenseal root extract
|
NPDI-jrKjdQ
|
Goldenseal (Hydrastis canadensis)
|
Differential inhibition of CYP1-catalyzed regioselective hydroxylation of estradiol by berberine and its oxidative metabolites
|
CYP1A2 Inhibition by Berberine
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
17-beta-estradiol
|
2-hydroxyestradiol
|
berberine
|
NPDI-2ugVjg
|
Goldenseal (Hydrastis canadensis)
|
Poor permeability and absorption affect the activity of four alkaloids from Coptis
|
Efflux of Berberine through P-gp
|
In Vitro Transporter Kinetics
|
negative
— No In Vitro Transport Activity
|
|
|
berberine
|
|
|
NPDI-u1oBIg
|
Goldenseal (Hydrastis canadensis)
|
Enzyme-inducing effects of berberine on cytochrome P450 1A2 in vitro and in vivo
|
In Vitro CYP1A2 Induction
|
In Vitro Enzyme Induction
|
positive
— In Vitro Enzyme Induction
|
|
|
|
|
acetaminophen
|
NPDI-8msv7A
|
Goldenseal (Hydrastis canadensis)
|
Enzyme-inducing effects of berberine on cytochrome P450 1A2 in vitro and in vivo
|
Induction of CYP1A2 Measured by mRNA Expression
|
In Vitro Enzyme Induction
|
positive
— In Vitro Enzyme Induction
|
|
|
|
|
acetaminophen
|
NPDI-oYawZw
|
Goldenseal (Hydrastis canadensis)
|
Poor permeability and absorption affect the activity of four alkaloids from Coptis
|
P-gp Permeability of Berberine Induced by Verapamil
|
In Vitro Transporter Inhibition
|
positive
— In Vitro Transporter Inhibition
|
|
|
berberine
|
|
verapamil
|
NPDI-mUlTOw
|
Goldenseal (Hydrastis canadensis)
|
Organic anion-transporting polypeptides contribute to the hepatic uptake of berberine
|
BBR-OATP1B1
|
In Vitro Transporter Kinetics
|
negative
— No In Vitro Transport Activity
|
|
|
berberine
|
|
|
NPDI-kt6jEg
|
Goldenseal (Hydrastis canadensis)
|
Organic anion-transporting polypeptides contribute to the hepatic uptake of berberine
|
Transport of Berberine by OAT1B3
|
In Vitro Transporter Kinetics
|
positive
— In Vitro Transport
|
|
|
berberine
|
|
|
NPDI-FWZOMQ
|
Goldenseal (Hydrastis canadensis)
|
Tetrandrine Potentiates the Hypoglycemic Efficacy of Berberine by Inhibiting P-Glycoprotein Function
|
Reduced Efflux of Berberine Through P-gp
|
In Vitro Transporter Inhibition
|
positive
— In Vitro Transporter Inhibition
|
|
|
berberine
|
|
tetrandrine
|
NPDI-ZdbG7w
|
Goldenseal (Hydrastis canadensis)
|
The Effect of Oxidation on Berberine-Mediated CYP1 Inhibition: Oxidation Behavior and Metabolite-Mediated Inhibition
|
CYP1A2 preincubation w/o NADPH
|
In Vitro Enzyme Inhibition
|
negative
— In Vitro Enzyme Negligible Inhibition
|
|
|
7-ethoxyresorufin
|
resorufin
|
berberine
|
NPDI-5sDXyA
|
Goldenseal (Hydrastis canadensis)
|
The Effect of Oxidation on Berberine-Mediated CYP1 Inhibition: Oxidation Behavior and Metabolite-Mediated Inhibition
|
CYP1A1 preincubation with NADPH
|
In Vitro Enzyme Inhibition
|
negative
— In Vitro Enzyme Negligible Inhibition
|
|
|
7-ethoxyresorufin
|
resorufin
|
berberine
|
NPDI-NAiMNw
|
Goldenseal (Hydrastis canadensis)
|
The Effect of Oxidation on Berberine-Mediated CYP1 Inhibition: Oxidation Behavior and Metabolite-Mediated Inhibition
|
Pre-incubation w/o NADPH
|
In Vitro Enzyme Inhibition
|
negative
— In Vitro Enzyme Negligible Inhibition
|
|
|
7-ethoxyresorufin
|
resorufin
|
berberine
|
NPDI-jjh4MA
|
Goldenseal (Hydrastis canadensis)
|
The Effect of Oxidation on Berberine-Mediated CYP1 Inhibition: Oxidation Behavior and Metabolite-Mediated Inhibition
|
1A2 pre-incubation with NADPH
|
In Vitro Enzyme Inhibition
|
negative
— In Vitro Enzyme Negligible Inhibition
|
|
|
7-ethoxyresorufin
|
resorufin
|
berberine
|
NPDI-hYXlNQ
|
Goldenseal (Hydrastis canadensis)
|
An ex vivo approach to botanical-drug interactions: A proof of concept study
|
3A4/5 Inhibition by Goldenseal
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
midazolam
|
1'-hydroxymidazolam
|
goldenseal root extract
|
NPDI-YlLZrw
|
Goldenseal (Hydrastis canadensis)
|
Identification of novel dietary phytochemicals inhibiting the efflux transporter breast cancer resistance protein (BCRP/ABCG2)
|
Inhibition of BCRP by Berberine
|
In Vitro Transporter Inhibition
|
positive
— In Vitro Transporter Inhibition
|
|
|
mitoxantrone
|
|
berberine
|
NPDI-jCImIg
|
Goldenseal (Hydrastis canadensis)
|
Identification of novel dietary phytochemicals inhibiting the efflux transporter breast cancer resistance protein (BCRP/ABCG2)
|
BCRP inhibition measured by accumulation
|
In Vitro Transporter Kinetics
|
positive
— In Vitro Transport
|
|
|
mitoxantrone
|
|
|
NPDI-a3Bf6g
|
Goldenseal (Hydrastis canadensis)
|
Inhibition of P-Glycoprotein by HIV Protease Inhibitors Increases Intracellular Accumulation of Berberine in Murine and Human Macrophages
|
Ritonavir P-gp Inhibition
|
In Vitro Transporter Kinetics
|
positive
— In Vitro Transport
|
|
|
berberine
|
|
|
NPDI-3z4F5w
|
Goldenseal (Hydrastis canadensis)
|
Inhibition of P-Glycoprotein by HIV Protease Inhibitors Increases Intracellular Accumulation of Berberine in Murine and Human Macrophages
|
Amprenavir P-gp Inhibition
|
In Vitro Transporter Kinetics
|
positive
— In Vitro Transport
|
|
|
berberine
|
|
|
NPDI-VpSvoQ
|
Goldenseal (Hydrastis canadensis)
|
Inhibition of P-Glycoprotein by HIV Protease Inhibitors Increases Intracellular Accumulation of Berberine in Murine and Human Macrophages
|
Lopinavir P-gp Inhibition
|
In Vitro Transporter Kinetics
|
positive
— In Vitro Transport
|
|
|
berberine
|
|
|
NPDI-PaRJNQ
|
Goldenseal (Hydrastis canadensis)
|
An ex vivo approach to botanical-drug interactions: A proof of concept study
|
3A4/5 Inhibition by Berberine (PB)
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
midazolam
|
1'-hydroxymidazolam
|
berberine
|
NPDI-6AJ-fg
|
Goldenseal (Hydrastis canadensis)
|
An ex vivo approach to botanical-drug interactions: A proof of concept study
|
3A4/5 Inhibition by Hydrastine (PB)
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
midazolam
|
1'-hydroxymidazolam
|
hydrastine
|
NPDI-KGE4lw
|
Goldenseal (Hydrastis canadensis)
|
An ex vivo approach to botanical-drug interactions: A proof of concept study
|
3A4/5 Inhibition by Berberine (Plasma)
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
midazolam
|
1'-hydroxymidazolam
|
berberine
|
NPDI-gAs6gw
|
Goldenseal (Hydrastis canadensis)
|
An ex vivo approach to botanical-drug interactions: A proof of concept study
|
3A4/5 Inhibition by Hydrastine (Plasma)
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
midazolam
|
1'-hydroxymidazolam
|
hydrastine
|
NPDI-gJxFZQ
|
Goldenseal (Hydrastis canadensis)
|
Inhibition of organic cation transporter 2 and 3 may be involved in the mechanism of the antidepressant-like action of berberine
|
OCT2 Inhibition by Berberine (5-HT)
|
In Vitro Transporter Inhibition
|
positive
— In Vitro Transporter Inhibition
|
|
|
serotonin
|
|
berberine
|
NPDI-rR-2qg
|
Goldenseal (Hydrastis canadensis)
|
Inhibition of organic cation transporter 2 and 3 may be involved in the mechanism of the antidepressant-like action of berberine
|
OCT2 Inhibition by Berberine (NE)
|
In Vitro Transporter Inhibition
|
positive
— In Vitro Transporter Inhibition
|
|
|
norepinephrine
|
|
berberine
|
NPDI-5R4-8g
|
Goldenseal (Hydrastis canadensis)
|
Inhibition of organic cation transporter 2 and 3 may be involved in the mechanism of the antidepressant-like action of berberine
|
Berberine Transport by OCT2
|
In Vitro Transporter Kinetics
|
positive
— In Vitro Transport
|
|
|
berberine
|
|
|
NPDI-zv6CYw
|
Goldenseal (Hydrastis canadensis)
|
Vectorial transport of the plant alkaloid berberine by double-transfected cells expressing the human organic cation transporter 1 (OCT1, SLC22A1) and the efflux pump MDR1 P-glycoprotein (ABCB1)
|
Berberine Transport by OCT1
|
In Vitro Transporter Kinetics
|
positive
— In Vitro Transport
|
|
|
berberine
|
|
|
NPDI-PeLrDg
|
Goldenseal (Hydrastis canadensis)
|
Vectorial transport of the plant alkaloid berberine by double-transfected cells expressing the human organic cation transporter 1 (OCT1, SLC22A1) and the efflux pump MDR1 P-glycoprotein (ABCB1)
|
Berberine Transport by OCT2
|
In Vitro Transporter Kinetics
|
positive
— In Vitro Transport
|
|
|
berberine
|
|
|
NPDI-ldcSbA
|
Goldenseal (Hydrastis canadensis)
|
Vectorial transport of the plant alkaloid berberine by double-transfected cells expressing the human organic cation transporter 1 (OCT1, SLC22A1) and the efflux pump MDR1 P-glycoprotein (ABCB1)
|
P-gp Transport of Berberine
|
In Vitro Transporter Kinetics
|
positive
— In Vitro Transport
|
|
|
berberine
|
|
|
NPDI-jjfDSA
|
Goldenseal (Hydrastis canadensis)
|
Effects of Herbal Products and their Constituents on Human Cytochrome P4502E1 Activity
|
CYP2E1 Inhibition by GS root extract
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
p-nitrophenol
|
4-nitrophenyl sulfate
|
goldenseal root extract
|
NPDI-Wkqo4w
|
Goldenseal (Hydrastis canadensis)
|
Effects of Herbal Products and their Constituents on Human Cytochrome P4502E1 Activity
|
CYP2E1 Inhibition by Berberine
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
p-nitrophenol
|
4-nitrophenyl sulfate
|
berberine
|
NPDI-aGqWbw
|
Goldenseal (Hydrastis canadensis)
|
Effects of Herbal Products and their Constituents on Human Cytochrome P4502E1 Activity
|
2E1 Inhibition by Hydrastine
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
p-nitrophenol
|
4-nitrophenyl sulfate
|
hydrastine
|
NPDI-VqNO0Q
|
Goldenseal (Hydrastis canadensis)
|
An in vitro Evaluation of Cytochrome P450 Inhibition and P-Glycoprotein Interaction with Goldenseal, Ginkgo biloba, Grape Seed, Milk Thistle, and Ginseng Extracts and Their Constituents
|
2C8 Inhibition by Hydrastine
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
paclitaxel
|
6-alpha-hydroxy paclitaxel
|
hydrastine
|
NPDI-5wiIYg
|
Goldenseal (Hydrastis canadensis)
|
An in vitro Evaluation of Cytochrome P450 Inhibition and P-Glycoprotein Interaction with Goldenseal, Ginkgo biloba, Grape Seed, Milk Thistle, and Ginseng Extracts and Their Constituents
|
3A4 Inhibition by Hydrastine (Testosterone)
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
testosterone
|
6beta-hydroxytestosterone
|
hydrastine
|
NPDI-dgm1Ww
|
Goldenseal (Hydrastis canadensis)
|
An in vitro Evaluation of Cytochrome P450 Inhibition and P-Glycoprotein Interaction with Goldenseal, Ginkgo biloba, Grape Seed, Milk Thistle, and Ginseng Extracts and Their Constituents
|
2C9 Inhibition by Hydrastine
|
In Vitro Enzyme Inhibition
|
negative
— In Vitro Enzyme Negligible Inhibition
|
|
|
tolbutamide
|
hydroxymethyltolbutamide
|
hydrastine
|
NPDI-6cuc3g
|
Goldenseal (Hydrastis canadensis)
|
An in vitro Evaluation of Cytochrome P450 Inhibition and P-Glycoprotein Interaction with Goldenseal, Ginkgo biloba, Grape Seed, Milk Thistle, and Ginseng Extracts and Their Constituents
|
2C19 Inhibition by Hydrastine
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
mephenytoin, (s)-
|
4-hydroxymephenytoin, (s)-
|
hydrastine
|
NPDI-2kECKw
|
Goldenseal (Hydrastis canadensis)
|
An in vitro Evaluation of Cytochrome P450 Inhibition and P-Glycoprotein Interaction with Goldenseal, Ginkgo biloba, Grape Seed, Milk Thistle, and Ginseng Extracts and Their Constituents
|
2C8 Inhibition by Berberine
|
In Vitro Enzyme Inhibition
|
negative
— In Vitro Enzyme Negligible Inhibition
|
|
|
paclitaxel
|
6-alpha-hydroxy paclitaxel
|
berberine
|
NPDI-c2kfPA
|
Goldenseal (Hydrastis canadensis)
|
An in vitro Evaluation of Cytochrome P450 Inhibition and P-Glycoprotein Interaction with Goldenseal, Ginkgo biloba, Grape Seed, Milk Thistle, and Ginseng Extracts and Their Constituents
|
2C19 Inhibition by Berberine
|
In Vitro Enzyme Inhibition
|
negative
— In Vitro Enzyme Negligible Inhibition
|
|
|
mephenytoin, (s)-
|
4-hydroxymephenytoin, (s)-
|
berberine
|
NPDI-cRrAsg
|
Goldenseal (Hydrastis canadensis)
|
An in vitro Evaluation of Cytochrome P450 Inhibition and P-Glycoprotein Interaction with Goldenseal, Ginkgo biloba, Grape Seed, Milk Thistle, and Ginseng Extracts and Their Constituents
|
2D6 Inhibition by Berberine
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
dextromethorphan
|
dextrorphan
|
berberine
|
NPDI-1ijwVg
|
Goldenseal (Hydrastis canadensis)
|
An in vitro Evaluation of Cytochrome P450 Inhibition and P-Glycoprotein Interaction with Goldenseal, Ginkgo biloba, Grape Seed, Milk Thistle, and Ginseng Extracts and Their Constituents
|
3A4 Inhibition by Berberine (Testosterone)
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
testosterone
|
6beta-hydroxytestosterone
|
berberine
|
NPDI-cesmqQ
|
Goldenseal (Hydrastis canadensis)
|
An in vitro Evaluation of Cytochrome P450 Inhibition and P-Glycoprotein Interaction with Goldenseal, Ginkgo biloba, Grape Seed, Milk Thistle, and Ginseng Extracts and Their Constituents
|
2C8 Inhibition by Ethanolic GS Extract
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
paclitaxel
|
6-alpha-hydroxy paclitaxel
|
ethanolic goldenseal extract
|
NPDI-uBMfpQ
|
Goldenseal (Hydrastis canadensis)
|
An in vitro Evaluation of Cytochrome P450 Inhibition and P-Glycoprotein Interaction with Goldenseal, Ginkgo biloba, Grape Seed, Milk Thistle, and Ginseng Extracts and Their Constituents
|
2C9 Inhibition by Ethanolic GS Extract
|
In Vitro Enzyme Inhibition
|
negative
— In Vitro Enzyme Negligible Inhibition
|
|
|
tolbutamide
|
hydroxymethyltolbutamide
|
ethanolic goldenseal extract
|
NPDI-3QKJaw
|
Goldenseal (Hydrastis canadensis)
|
An in vitro Evaluation of Cytochrome P450 Inhibition and P-Glycoprotein Interaction with Goldenseal, Ginkgo biloba, Grape Seed, Milk Thistle, and Ginseng Extracts and Their Constituents
|
2C19 Inhibition by Ethanolic GS Extract
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
mephenytoin, (s)-
|
4-hydroxymephenytoin, (s)-
|
ethanolic goldenseal extract
|
NPDI-PqZKVg
|
Goldenseal (Hydrastis canadensis)
|
An in vitro Evaluation of Cytochrome P450 Inhibition and P-Glycoprotein Interaction with Goldenseal, Ginkgo biloba, Grape Seed, Milk Thistle, and Ginseng Extracts and Their Constituents
|
2D6 Inhibition by Ethanolic GS Extract
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
dextromethorphan
|
dextrorphan
|
ethanolic goldenseal extract
|
NPDI-cnkDpg
|
Goldenseal (Hydrastis canadensis)
|
An in vitro Evaluation of Cytochrome P450 Inhibition and P-Glycoprotein Interaction with Goldenseal, Ginkgo biloba, Grape Seed, Milk Thistle, and Ginseng Extracts and Their Constituents
|
3A4 Inhibition by Ethanolic GS Extract (MDZ)
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
midazolam
|
1'-hydroxymidazolam
|
ethanolic goldenseal extract
|
NPDI-ibIkjQ
|
Goldenseal (Hydrastis canadensis)
|
An in vitro Evaluation of Cytochrome P450 Inhibition and P-Glycoprotein Interaction with Goldenseal, Ginkgo biloba, Grape Seed, Milk Thistle, and Ginseng Extracts and Their Constituents
|
3A4 Inhibition by Ethanolic GS Extract (Testosterone)
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
testosterone
|
6beta-hydroxytestosterone
|
ethanolic goldenseal extract
|
NPDI-37V97Q
|
Goldenseal (Hydrastis canadensis)
|
An in vitro Evaluation of Cytochrome P450 Inhibition and P-Glycoprotein Interaction with Goldenseal, Ginkgo biloba, Grape Seed, Milk Thistle, and Ginseng Extracts and Their Constituents
|
2C8 Inhibition by Aq GS Extract
|
In Vitro Enzyme Inhibition
|
negative
— In Vitro Enzyme Negligible Inhibition
|
|
|
paclitaxel
|
6-alpha-hydroxy paclitaxel
|
aqueous goldenseal extract
|
NPDI-0_ey6g
|
Goldenseal (Hydrastis canadensis)
|
An in vitro Evaluation of Cytochrome P450 Inhibition and P-Glycoprotein Interaction with Goldenseal, Ginkgo biloba, Grape Seed, Milk Thistle, and Ginseng Extracts and Their Constituents
|
2C19 Inhibition by Aq GS Extract
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
mephenytoin, (s)-
|
4-hydroxymephenytoin, (s)-
|
aqueous goldenseal extract
|
NPDI-IdieOw
|
Goldenseal (Hydrastis canadensis)
|
An in vitro Evaluation of Cytochrome P450 Inhibition and P-Glycoprotein Interaction with Goldenseal, Ginkgo biloba, Grape Seed, Milk Thistle, and Ginseng Extracts and Their Constituents
|
2D6 Inhibition by Aq GS Extract
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
dextromethorphan
|
dextrorphan
|
aqueous goldenseal extract
|
NPDI-Z0x9xQ
|
Goldenseal (Hydrastis canadensis)
|
An in vitro Evaluation of Cytochrome P450 Inhibition and P-Glycoprotein Interaction with Goldenseal, Ginkgo biloba, Grape Seed, Milk Thistle, and Ginseng Extracts and Their Constituents
|
3A4 Inhibition by Aq GS Extract (MDZ)
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
midazolam
|
1'-hydroxymidazolam
|
aqueous goldenseal extract
|
NPDI--K80vw
|
Goldenseal (Hydrastis canadensis)
|
Human Cytochrome P450 Inhibition and Metabolic-Intermediate Complex Formation By Goldenseal Extract and Its Methylenedioxyphenyl Components
|
2C9 Inhibition by GS Extract
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
diclofenac
|
4'-hydroxydiclofenac
|
goldenseal root extract
|
NPDI-OCQ06Q
|
Goldenseal (Hydrastis canadensis)
|
Human Cytochrome P450 Inhibition and Metabolic-Intermediate Complex Formation By Goldenseal Extract and Its Methylenedioxyphenyl Components
|
3A4 Inhibition by GS Extract
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
testosterone
|
6beta-hydroxytestosterone
|
goldenseal root extract
|
NPDI-qzY27Q
|
Goldenseal (Hydrastis canadensis)
|
Human Cytochrome P450 Inhibition and Metabolic-Intermediate Complex Formation By Goldenseal Extract and Its Methylenedioxyphenyl Components
|
2D6 Inhibition by GS Extract
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
bufuralol
|
1'-hydroxybufuralol
|
goldenseal root extract
|
NPDI-d4PkwQ
|
Goldenseal (Hydrastis canadensis)
|
Human MDR1 and MRP1 Recognize Berberine as Their Transport Substrate
|
Berberine Transport by P-gp
|
In Vitro Transporter Kinetics
|
positive
— In Vitro Transport
|
|
|
berberine
|
|
|
NPDI-IXEC2g
|
Goldenseal (Hydrastis canadensis)
|
Human MDR1 and MRP1 Recognize Berberine as Their Transport Substrate
|
Control P-gp
|
In Vitro Transporter Kinetics
(Control experiment)
|
positive
— In Vitro Transport
|
|
|
berberine
|
|
|
NPDI-iSHQYQ
|
Goldenseal (Hydrastis canadensis)
|
Human Cytochrome P450 Inhibition and Metabolic-Intermediate Complex Formation By Goldenseal Extract and Its Methylenedioxyphenyl Components
|
2C9 Inhibition by Berberine
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
diclofenac
|
4'-hydroxydiclofenac
|
berberine
|
NPDI-LNDazQ
|
Goldenseal (Hydrastis canadensis)
|
Human Cytochrome P450 Inhibition and Metabolic-Intermediate Complex Formation By Goldenseal Extract and Its Methylenedioxyphenyl Components
|
2D6 Inhibition by Berberine
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
bufuralol
|
1'-hydroxybufuralol
|
berberine
|
NPDI-_D6yiA
|
Goldenseal (Hydrastis canadensis)
|
Human Cytochrome P450 Inhibition and Metabolic-Intermediate Complex Formation By Goldenseal Extract and Its Methylenedioxyphenyl Components
|
3A4 Inhibition by Berberine
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
testosterone
|
6beta-hydroxytestosterone
|
berberine
|
NPDI-w-6ghw
|
Goldenseal (Hydrastis canadensis)
|
Human Cytochrome P450 Inhibition and Metabolic-Intermediate Complex Formation By Goldenseal Extract and Its Methylenedioxyphenyl Components
|
2D6 Inhibition by (+) Hydrastine
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
bufuralol
|
1'-hydroxybufuralol
|
hydrastine
|
NPDI-39rhWg
|
Goldenseal (Hydrastis canadensis)
|
Human Cytochrome P450 Inhibition and Metabolic-Intermediate Complex Formation By Goldenseal Extract and Its Methylenedioxyphenyl Components
|
3A4 Inhibition by (+) Hydrastine
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
testosterone
|
6beta-hydroxytestosterone
|
hydrastine
|
NPDI-3M10oA
|
Goldenseal (Hydrastis canadensis)
|
Human Cytochrome P450 Inhibition and Metabolic-Intermediate Complex Formation By Goldenseal Extract and Its Methylenedioxyphenyl Components
|
2C9 Inhibition by (+) Hydrastine
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
diclofenac
|
4'-hydroxydiclofenac
|
hydrastine
|
NPDI-wdarow
|
Goldenseal (Hydrastis canadensis)
|
Human Cytochrome P450 Inhibition and Metabolic-Intermediate Complex Formation By Goldenseal Extract and Its Methylenedioxyphenyl Components
|
2C9 Inhibition by (-) Hydrastine
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
diclofenac
|
4'-hydroxydiclofenac
|
(-)-beta-hydrastine
|
NPDI-CDvKlQ
|
Goldenseal (Hydrastis canadensis)
|
Human Cytochrome P450 Inhibition and Metabolic-Intermediate Complex Formation By Goldenseal Extract and Its Methylenedioxyphenyl Components
|
3A4 Inhibition by (-) Hydrastine
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
testosterone
|
6beta-hydroxytestosterone
|
(-)-beta-hydrastine
|
NPDI-UaWFPQ
|
Goldenseal (Hydrastis canadensis)
|
Human Cytochrome P450 Inhibition and Metabolic-Intermediate Complex Formation By Goldenseal Extract and Its Methylenedioxyphenyl Components
|
2D6 Inhibition by (-) Hydrastine
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
bufuralol
|
1'-hydroxybufuralol
|
(-)-beta-hydrastine
|
NPDI-_UID1w
|
Goldenseal (Hydrastis canadensis)
|
An in vitro Evaluation of Cytochrome P450 Inhibition and P-Glycoprotein Interaction with Goldenseal, Ginkgo biloba, Grape Seed, Milk Thistle, and Ginseng Extracts and Their Constituents
|
3A4 Inhibition by Hydrastine (MDZ)
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
midazolam
|
1'-hydroxymidazolam
|
hydrastine
|
NPDI-59mQTg
|
Goldenseal (Hydrastis canadensis)
|
An in vitro Evaluation of Cytochrome P450 Inhibition and P-Glycoprotein Interaction with Goldenseal, Ginkgo biloba, Grape Seed, Milk Thistle, and Ginseng Extracts and Their Constituents
|
1A2 Inhibition by Hydrastine
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
acetanilide
|
acetaminophen
|
hydrastine
|
NPDI-ij84RA
|
Goldenseal (Hydrastis canadensis)
|
An in vitro Evaluation of Cytochrome P450 Inhibition and P-Glycoprotein Interaction with Goldenseal, Ginkgo biloba, Grape Seed, Milk Thistle, and Ginseng Extracts and Their Constituents
|
2E1 Inhibition by Berberine
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
p-nitrophenol
|
4-nitrophenyl sulfate
|
berberine
|
NPDI-oVpWlA
|
Goldenseal (Hydrastis canadensis)
|
An in vitro Evaluation of Cytochrome P450 Inhibition and P-Glycoprotein Interaction with Goldenseal, Ginkgo biloba, Grape Seed, Milk Thistle, and Ginseng Extracts and Their Constituents
|
1A2 Inhibition by Ethanolic GS Extract
|
In Vitro Enzyme Inhibition
|
negative
— In Vitro Enzyme Negligible Inhibition
|
|
|
acetanilide
|
acetaminophen
|
ethanolic goldenseal extract
|
NPDI-cYwbww
|
Goldenseal (Hydrastis canadensis)
|
An in vitro Evaluation of Cytochrome P450 Inhibition and P-Glycoprotein Interaction with Goldenseal, Ginkgo biloba, Grape Seed, Milk Thistle, and Ginseng Extracts and Their Constituents
|
3A4 Inhibition by Aq GS Extract (Testosterone)
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
testosterone
|
6beta-hydroxytestosterone
|
aqueous goldenseal extract
|
NPDI-OFFj8Q
|
Goldenseal (Hydrastis canadensis)
|
An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures
|
3A4 Inhibition by Berberine
|
In Vitro Enzyme Inhibition
|
positive
— In Vitro Enzyme Inhibition
|
|
|
7-ethoxyresorufin
|
resorufin
|
berberine
|
NPDI-6gn9Dg
|
Goldenseal (Hydrastis canadensis)
|
An in vitro Evaluation of Cytochrome P450 Inhibition and P-Glycoprotein Interaction with Goldenseal, Ginkgo biloba, Grape Seed, Milk Thistle, and Ginseng Extracts and Their Constituents
|
2D6 Inhibition by Hydrastine
|
In Vitro Enzyme Inhibition
|
negative
— In Vitro Enzyme Negligible Inhibition
|
|
|
dextromethorphan
|
dextrorphan
|
hydrastine
|
NPDI-NNibEQ
|
Goldenseal (Hydrastis canadensis)
|
An in vitro Evaluation of Cytochrome P450 Inhibition and P-Glycoprotein Interaction with Goldenseal, Ginkgo biloba, Grape Seed, Milk Thistle, and Ginseng Extracts and Their Constituents
|
2E1 Inhibition by Hydrastine
|
In Vitro Enzyme Inhibition
|
negative
— In Vitro Enzyme Negligible Inhibition
|
|
|
p-nitrophenol
|
4-nitrophenyl sulfate
|
hydrastine
|
NPDI-bcNEPw
|
Goldenseal (Hydrastis canadensis)
|
A clinical study of transporter-mediated goldenseal drug interactions
|
clinical goldenseal - furosemide experiment
|
In Vivo Interaction
|
negative
— No Effect (based on bioequivalence limits)
|
|
- OAT1 (SLC22A6)
- OAT3 (SLC22A8)
|
furosemide
|
|
goldenseal root extract
|
NPDI-_zSDOQ
|
Goldenseal (Hydrastis canadensis)
|
A clinical study of transporter-mediated goldenseal drug interactions
|
clinical goldenseal - metformin study
|
In Vivo Interaction
|
positive
— PK Interaction - Decreased systemic exposure
|
|
- MATE1 (SLC47A1)
- MATE2-K (SLC47A2)
- OCT1 (SLC22A1)
- OCT2 (SLC22A2)
|
metformin
|
|
goldenseal root extract
|
NPDI-DboNmw
|
Goldenseal (Hydrastis canadensis)
|
A clinical study of transporter-mediated goldenseal drug interactions
|
clinical goldenseal - midazolam experiment
|
In Vivo Interaction
|
positive
— PK Interaction - Increased systemic exposure
|
|
|
midazolam
|
|
goldenseal root extract
|
NPDI-8KuZrA
|
Goldenseal (Hydrastis canadensis)
|
A clinical study of transporter-mediated goldenseal drug interactions
|
clinical goldenseal - rosuvastatin acid experiment
|
In Vivo Interaction
|
negative
— No Effect (based on bioequivalence limits)
|
|
- BCRP (ABCG2)
- OATP1B1 (SLCO1B1)
- OATP1B3 (SLCO1B3)
|
rosuvastatin
|
|
goldenseal root extract
|
NPDI-M015vQ
|
Goldenseal (Hydrastis canadensis)
|
A clinical study of transporter-mediated goldenseal drug interactions
|
clinical goldenseal - rosuvastatin lactone experiment
|
In Vivo Interaction
|
negative
— No Effect (based on bioequivalence limits)
|
|
- OATP1B1 (SLCO1B1)
- OATP1B3 (SLCO1B3)
|
rosuvastatin lactone
|
|
goldenseal root extract
|
NPDI-xD43_Q
|
Goldenseal (Hydrastis canadensis)
|
Goldenseal root extract Nuclear Receptor Induction study - Ole Miss
|
Goldenseal - In Vitro Nuclear Receptor Induction PXR Experiment - 1
|
In Vitro Nuclear Receptor Induction
|
negative
— In Vitro Nuclear Receptor Non-induction
|
- Pregnane X receptor (PXR)
|
|
|
|
goldenseal root extract
|
NPDI-pY8Kvw
|
Goldenseal (Hydrastis canadensis)
|
Goldenseal root extract Nuclear Receptor Induction study - Ole Miss
|
Goldenseal - In Vitro Nuclear Receptor Induction PXR Experiment - 2
|
In Vitro Nuclear Receptor Induction
|
negative
— In Vitro Nuclear Receptor Non-induction
|
- Pregnane X receptor (PXR)
|
|
|
|
goldenseal root extract
|
NPDI-pgGq0g
|
Goldenseal (Hydrastis canadensis)
|
Goldenseal root extract Nuclear Receptor Induction study - Ole Miss
|
Goldenseal - In Vitro Nuclear Receptor Induction PXR Experiment - 3
|
In Vitro Nuclear Receptor Induction
|
negative
— In Vitro Nuclear Receptor Non-induction
|
- Pregnane X receptor (PXR)
|
|
|
|
goldenseal root extract
|
NPDI-_uEXTQ
|
Goldenseal (Hydrastis canadensis)
|
Goldenseal root extract Nuclear Receptor Induction study - Ole Miss
|
Goldenseal - In Vitro Nuclear Receptor Induction AHR Experiment - 1
|
In Vitro Nuclear Receptor Induction
|
positive
— In Vitro Nuclear Receptor Induction
|
- Aryl hydrocarbon receptor (AHR)
|
|
|
|
goldenseal root extract
|
NPDI-UGfCNQ
|
Goldenseal (Hydrastis canadensis)
|
Goldenseal root extract Nuclear Receptor Induction study - Ole Miss
|
Goldenseal - In Vitro Nuclear Receptor Induction AHR Experiment - 3
|
In Vitro Nuclear Receptor Induction
|
positive
— In Vitro Nuclear Receptor Induction
|
- Aryl hydrocarbon receptor (AHR)
|
|
|
|
goldenseal root extract
|
NPDI-pCWDFA
|
Goldenseal (Hydrastis canadensis)
|
Goldenseal root extract Nuclear Receptor Induction study - Ole Miss
|
Goldenseal - In Vitro Nuclear Receptor Induction AHR Experiment - 2
|
In Vitro Nuclear Receptor Induction
|
positive
— In Vitro Nuclear Receptor Induction
|
- Aryl hydrocarbon receptor (AHR)
|
|
|
|
goldenseal root extract
|
NPDI-_tymTQ
|
Goldenseal (Hydrastis canadensis)
|
R21 Goldenseal Project
|
Inhibition of PMAT by Goldenseal
|
In Vitro Transporter Inhibition
|
positive
— In Vitro Transporter Inhibition
|
|
|
mpp+
|
|
goldenseal root extract
|
NPDI-eiNjiQ
|
Goldenseal (Hydrastis canadensis)
|
R21 Goldenseal Project
|
Inhibition of PMAT by Berberine
|
In Vitro Transporter Inhibition
|
positive
— In Vitro Transporter Inhibition
|
|
|
mpp+
|
|
berberine
|
NPDI-g3SJcw
|
Goldenseal (Hydrastis canadensis)
|
R21 Goldenseal Project
|
Inhibition of THTR2 by Goldenseal
|
In Vitro Transporter Inhibition
|
positive
— In Vitro Transporter Inhibition
|
|
|
thiamine
|
|
goldenseal root extract
|
NPDI-NyZpzA
|
Goldenseal (Hydrastis canadensis)
|
R21 Goldenseal Project
|
Inhibition of THTR2 by Berberine
|
In Vitro Transporter Inhibition
|
positive
— In Vitro Transporter Inhibition
|
|
|
thiamine
|
|
berberine
|
NPDI-ofSGNw
|
Goldenseal (Hydrastis canadensis)
|
R21 Goldenseal Project
|
Inhibition of OCT3 by Berberine
|
In Vitro Transporter Inhibition
|
positive
— In Vitro Transporter Inhibition
|
|
|
mpp+
|
|
berberine
|
NPDI-WdP3OQ
|
Goldenseal (Hydrastis canadensis)
|
R21 Goldenseal Project
|
Inhibition of OCT3 by Goldenseal
|
In Vitro Transporter Inhibition
|
positive
— In Vitro Transporter Inhibition
|
|
|
mpp+
|
|
goldenseal root extract
|
NPDI-dS7vAQ
|
Goldenseal (Hydrastis canadensis)
|
R21 Goldenseal Project
|
Oral Metformin/Oral Inhibitor Mouse Study - Goldenseal Extract
|
In Vivo Interaction
|
positive
— PK Interaction - Decreased systemic exposure
|
|
|
metformin
|
|
aqueous goldenseal extract
|
NPDI-KWj0Jg
|
Goldenseal (Hydrastis canadensis)
|
R21 Goldenseal Project
|
Oral Metformin/Oral Inhibitor Mouse Study - Berberine
|
In Vivo Interaction
|
negative
— No Effect (based on bioequivalence limits)
|
|
|
metformin
|
|
berberine
|
NPDI-yehRxQ
|
Goldenseal (Hydrastis canadensis)
|
R21 Goldenseal Project
|
Oral Metformin/Oral Inhibitor Mouse Study - (-)-β-hydrastine
|
In Vivo Interaction
|
negative
— No Effect (based on bioequivalence limits)
|
|
|
metformin
|
|
(-)-beta-hydrastine
|
NPDI-yewsDg
|
Goldenseal (Hydrastis canadensis)
|
R21 Goldenseal Project
|
Oral Metformin/Oral Inhibitor Mouse Study - Imatinib
|
In Vivo Interaction
|
positive
— PK Interaction - Decreased systemic exposure
|
|
|
metformin
|
|
imatinib
|
NPDI-n4yXtA
|
Goldenseal (Hydrastis canadensis)
|
R21 Goldenseal Project
|
Intravenous Metformin/Oral Inhibitor Mouse Study - Goldenseal Extract
|
In Vivo Interaction
|
negative
— No Effect (based on bioequivalence limits)
|
|
|
metformin
|
|
aqueous goldenseal extract
|
NPDI-YlzfNg
|
Goldenseal (Hydrastis canadensis)
|
R21 Goldenseal Project
|
Intravenous Metformin/Oral Inhibitor Mouse Study - Imatinib
|
In Vivo Interaction
|
negative
— No Effect (based on bioequivalence limits)
|
|
|
metformin
|
|
imatinib
|
NPDI-ZFajng
|
Goldenseal (Hydrastis canadensis)
|
Goldenseal Metabolomics
|
Goldenseal Metabolomics Experiment
|
Metabolomics
|
|
|
|
|
|
|